article
16 June 2016 | By Andreas Reimer (CEO: Tangea), Anton Simeonov, David Bailey (IOTA Pharmaceuticals), Ilyas Singeç (National Center for Advancing Translational Sciences), Sheraz Gul (Fraunhofer-IME SP)
Featured in this Stem Cells In-depth Focus: Translating stem cell biology into drug discovery; Mechanism-informed phenotypic screening – the missing link for cancer drug discovery; Analysis of human stem cell interactions at the single-cell resolution...